2894â€“2909 Nucleic Acids Research, 2009, Vol. 37,  9                                                           Published online 13 March 2009
doi:10.1093/nar/gkp152

 universal YrdC/Sua5 family required formation threonylcarbamoyladenosine tRNA
Basma El Yacoubi1, Benjamin Lyons1, Yulien Cruz1, Robert Reddy2, Brian Nordin2,
Fabio Agnelli2, James R. Williamson2, Paul Schimmel2, Manal  Swairjo2 ValeÂ´rie CreÂ´cy-Lagard1,*
1
 Department Microbiology Department Microbiology Cell Science, University Florida, P.O. Box
110700, Gainesville, FL 32611-0700 2Department Chemistry Department Molecular Biology, Skaggs Institute Chemical Biology, Scripps Research Institute, La Jolla, CA 92037, USA

Received November 4, 2008; Revised February 3, 2009; Accepted February 24, 2009



ABSTRACT                                                                        center proposed form nucleic-acid-binding
                                              6                                 site (2). Binding double-stranded RNA (including
Threonylcarbamoyladenosine (t  universal                                 tRNA) experimentally veriï¬?ed E. coli YrdC
modification position 37 ANN decoding                               protein (YrdCEc) (2). study COG0009 encoding
tRNAs, imparts unique structure                                  gene Saccharomyces cerevisiae, SUA5, preliminarily
anticodon loop enhancing binding ribosomes                               addressed function gene family. mutant vitro. Using combination bioinformatic,                                 allele, sua5-1 (Ser107 ! Phe replacement) identiï¬?ed
genetic, structural biochemical approaches,                                 suppressor translation initiation defect universal protein family YrdC/Sua5 (COG0009)                                leader region cyc1-1019 allele iso-1- shown involved biosynthesis                                 cytochrome c encoding gene CYC1. strain carrying hypermodified base. Contradictory reports                               cyc1-1019 allele, initiation shown occur essentiality yrdC wild-type gene                             aberrant stream frame ATG  single
                                                                                base-pair substitution) resulted expression 2 
Escherichia coli SUA5 wild-type gene                                                                                 normal Cyc1 protein  Interestingly, sup-
Saccharomyces cerevisiae led reconstruct                                  pression did occur transcriptional level null alleles genes prove yrdC                              observed sua suppressors identiï¬?ed essential E. coli, SUA5 dispensable                            screen (4). strain carrying sua5 null mutation
yeast results severe growth phenotypes.                                  sua5::LEU2 displayed pleiotropic phenotypes Structural biochemical analyses revealed                               included; slow growth, cytochrome a3 deï¬?ciency, E. coli YrdC protein binds ATP preferentially                           decreased cytochrome b levels inability grow binds RNAThr lacking t6A modification.                            lactate glycerol (4). Sua5 protein implicated
work lays foundation elucidating function                           post-transcriptional modulation gene expression protein family sequenced                                    biochemical function remained uncharacterized (4). genome date understanding role t6A                                humans, YrdC ortholog (YrdCH) identiï¬?ed                                                                                 retinoblastoma binding protein 10 (RBBP10) interactor vivo.
                                                                                possible role translation proposed based                                                                                 high ubiquitous expression proï¬?le tissues
                                                                                including high levels protein synthesis
INTRODUCTION                                                                    occurs (5). YrdCH ortholog identiï¬?ed sequenced genomes date, YrdC                                new ischemia/reperfusion-inducible protein (IRIP) (COG0009) family ranked 10                              indirectly regulates activity variety trans-
served hypothetical proteins considered high pri-                      porters probably interaction RSC1A1, ority targets experimental study (1). crystal                           modulator membrane transport unclear mode structures Escherichia coli COG0009 family mem-                          action (6).
bers YrdC YciO (2,3) reveal b twisted open-                               E. coli, small deletion 12 nucleotides including
sheet structure positively charged cleft                          initiation codon yrdC (yrdC) 
 correspondence addressed. Tel: +1 352 392 9416; Fax: +1 352 392 5922; Email: vcrecy@uï¬‚.edu
Present addresses:
Brian Nordin, ActivX Biosciences,  11025 North Torrey Pines Road, La Jolla, CA 92037, USA.
Manal  Swairjo, Burnham Institute Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.

ÃŸ 2009 Author(s) Open Access article distributed terms Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ nc/2.0/uk/) permits unrestricted non-commercial use, distribution, reproduction medium, provided original work properly cited.
                                                                          Nucleic Acids Research, 2009, Vol. 37,  9 2895


suppress temperature-sensitive phenotype caused           possible, building phylogenetic trees using prfA1  allele prfA gene encoding release factor        ClustalW tool (25) integrated SEED deriving spe-
1). mutations inseparable           ciï¬?c protein motifs (http://espript.ibcp.fr/ESPript/
function ribosome maturation suggested yrdC           ESPript/).
based observation double mutant dis-
played slightly higher amounts 17S rRNA, immature          Strains growth conditions
form 16S rRNA (7,8).                                          E. coli S. cerevisiae strains used study    summary, members COG009 family              listed Table 1. Bacteria routinely grown LB
act cellular regulators, pleiotropic eï¬€ects        medium (BD Diagnostics Systems) 37 C unless 
linked translation vary experimental            wise stated. Bacterial growth media solidiï¬?ed 15  Overall role molecular level           g/l agar (BD Diagnostics Systems) preparation YrdC/Sua5 proteins remained unclear. essentiality            plates. Transformation P1 transductions  gene family remained resolved issue,          formed following standard procedures (26). sensitivity appeared vary organism considered          P1 phage recipient strains used veriï¬?ed. approach utilized construct mutations. E. coli,     Ampicillin (Amp, 100 mg/ml), Kanamycin (Km, 50 mg/ml),
yrdC deletion mutant obtained systematic              L-Arabinose (Ara, 0.02Â—0.2 ), used appro-
single-gene knockout mutant collection,              priate. Bacterial chromosomal DNA prepared
E. coli homolog yciO successfully deleted             using Qiagen kit DNeasyÃ• Tissue Kit yeast chro- study (9).  yrdC mutant isolated         mosome DNA prepared using Blood & Tissue Kit prfA1 background, mutations dis-          (Qiagen, Valencia, CA).
sociable, suggesting gene yrdC essen-           Yeast strains routinely grown YPD (DIFCO
tial wild-type E. coli (8).  conï¬‚icting results       Laboratories) 30 C unless stated. Synthetic reported insertion Tn5-araPBAD            minimal, Agar, SD base SD base Gal/
construct ï¬?rst 15 bp yrdCEc did lead        Raf dropout (-uracil, -ura; -leucine, -leu;
lethality rich medium supplemented glucose (10).         -histidine,   purchased Clontech (Palo Alto,
   yeast, isolated suppressor,    CA) prepared recommended manufacturer.
sua5::LEU2 allele dissected away original           Glucose (Glu, 2 ), Glycerol (Gly, 4 ), 5-ï¬‚uoro-orotic
mutation, deletion gene successfully              acid (5-FOA, 0.1 ) G 418 (300 mg/ml) used
achieved homozygous backgrounds suggesting               appropriate. Transformations carried gene essential (4).  yeast sys-       described pYES-DEST52 manual (Invitrogen,
tematic gene deletion collection, single SUA5 copy       Carlsbad, CA). deleted diploid background BY4743, deletion obtained haploid background                  Cloning strains constructions
BY4741 (11).
   N6-threonylcarbamoyl adenosine (t6A) anticodon-         plasmids constructed listed Table 1. Sequences
loop modiï¬?cation position 37 tRNAs decod-            primers used given Table 2. E. coli wild-
ing ANN codons. considerable biochemical            type genes yrdCEc (NP_417741) yciOEc (NP_415783)
biophysical information exists function           ampliï¬?ed PCR genomic DNA prepared
hypermodiï¬?ed base (12Â—21), t6A biosynthesis pathway          strain E. coli K12 MG1655. similar fashion partially biochemically characterized          wild-type gene ywlCBs (NP_391576) ampliï¬?ed
shown ATP-dependent process requiring threo-            Bacillus subtilis 168 genomic DNA wild- carbonate genes involved        type yeast gene SUA5 (NP_011346) ampliï¬?ed biosynthesis identiï¬?ed (22).                       strain BY4743 genomic DNA. wild-type gene
   present study combining compar-           yrdCMm (NP 987306) ampliï¬?ed Methanococcus
ative genomic approach experimental validation         maripaludis S2 genomic DNA. subcloning YrdC/Sua5 family involved t6A biosynthesis.         pBAD24, forward primers (ol1) contained NcoI investigated essentiality gene family    sequence reverse primers (ol2) contained biological systems, E. coli yeast. light role   HindIII sequence, reverse primer amplify gene family formation critically impor-       SUA5 contained PstI site, BADEcyrdCol1/
tant tRNA modiï¬?cation t6A37, hypotheses explain          BADEcyrdCol2; BADEcyciOol1/BADEcyciOol2; BADB pleiotropic eï¬€ects observed previous studies       sywlCol1/BADBsywlCol2;           BADMmyrdCol1/BADM
presented.                                                       myrdCol2; BADsua5ol1/BADsua5ol2. PCR fragments
                                                                 ï¬?rst inserted pCR2.1 TOPO (Invitrogen)
                                                                 transformed 10 cells (Invitrogen)
MATERIALS METHODS                                            according manufacturer protocol. Sequences                                                                  veriï¬?ed subcloning appropriate sites Bioinformatics
                                                                 pBAD24 (27).
Analysis COG009 family performed                  subcloning pYES, PCR ampliï¬?ed
SEED database (23). used Blast tools             products corresponding yrdCEc, yciOEc, yrdCMm,
resources NCBI (24). Annotations paralog families         ywlCBs genes ï¬?rst cloned entry using physical clustering chromosome            vector      pENTR/D-TOPO           (Invitrogen),      using
 2896 Nucleic Acids Research, 2009, Vol. 37,  9


Table 1. Strains plasmids used

Strain       Relevant characteristics                                                                                   Reference

Yeast strains
BY4741            MATa his3D1 leu2D0 met15D0 ura3D0 (S288C)                                                                  (59)
BY4743            MATa/MAT his3-D1/his3-D1 leu2-D0/leu2-D0 lys2-D0/lys2-D0 ura3-0/ura3-0                                    (59)
VDC5118           YGN63 transformed plasmid pYES-DEST52; Ura+, Leu+                                                       study
VDC5119           YGN63 transformed plasmid pYES-DEST52; Ura+, Leu+                                                       study
VDC5120           YGN63 transformed plasmid pBY135; Ura+, Leu+                                                            study
VDC5121           YGN63 transformed plasmid pBY135; Ura+, Leu+                                                            study
VDC5122           YGN63 transformed plasmid pBY136; Ura+, Leu+                                                            study
VDC5123           YGN63 transformed plasmid pBY136; Ura+, Leu+                                                            study
VDC5124           YGN63 transformed plasmid pBY137; Ura+, Leu+                                                            study
VDC5125           YGN63 transformed plasmid pBY137; Ura+, Leu+                                                            study
VDC5126           YGN63 transformed plasmid pBY138; Ura+, Leu+                                                            study
VDC5127           YGN63 transformed plasmid pBY138; Ura+, Leu+                                                            study
VDC5300           Derivative BY4743; SUA5/sua5-D1::LEU2                                                                     study
VDC5309           Derivative BY4741 transformed pYES-DEST52::yrdCEc; Ura+                                              study
VDC5416           Derivative VDC5309; sua5-D1::LEU2; Ura+ Leu+                                                              study
VDC5417           Derivative VDC5309; SUA5; Ura+ Leu+                                                                       study
VDC5440           Derivative VDC5416 FOA treatment; sua5-D1::LEU2;Ura Leu+ (cured pYES-DEST52::yrdCEc),           study
                   clone 14
VDC5441           Derivative VDC5416 FOA treatment; sua5-D1::LEU2;Ura Leu+ (cured pYES-DEST52::yrdCEc),         study
                   clone 15
YJN63             MAT CYC cyc7-67 ura3-52 leu2-3,112 cyh2 sua5::LEU2                                                      (4)
YMH13             MAT cyc1Â—1019 cyc7-67 ura3Â—52 leu2Â—3,112 cyh2                                                             (4)
E. coli strains
BL21(DE3)         F ompT hsdSB(rBÂ—, mBÂ—) gal dcm (DE3)
E. coli TOP10     F mcrA (mrrhsdRMSmcrBC) j80lacZM15 lacX74 recA1 araD139 (ara-leu) 7697 galU galK rpsL               Invitrogen
                    (StrR) endA1 nupG
MG1655                                                                                                                       Coli Genetic
                                                                                                                               Stock Center
                                                             R
NM1100            rrnD rrnE)1, rph-1, att PLCI857 Red abgTet                                                              (60)
VDC5173           Derivative NM1100 yrdCEc-1::KmR/pBAD24::yrdCEc; KmR/AmpR                                               study
VDC5174           Derivative NM1100 yrdCEc-1::KmR/pBAD24::yrdCEc; KmR/AmpR                                               study
VDC5217           MG1655 transformed plasmid pBY125; AmpR                                                               study
VDC5218           MG1655 transformed plasmid pBY125; AmpR                                                               study
VDC5219           MG1655 transformed plasmid pBY126; AmpR                                                               study
VDC5220           MG1655 transformed plasmid pBY126; AmpR                                                               study
VDC5221           MG1655 transformed plasmid pBY128; AmpR                                                               study
VDC5222           MG1655 transformed plasmid pBY128; AmpR                                                               study
VDC5223           MG1655 transformed plasmid pBY130; AmpR                                                               study
VDC5224           MG1655 transformed plasmid pBY130; AmpR                                                               study
VDC5227           MG1655 transformed plasmid pBAD24; AmpR                                                               study
VDC5228           MG1655 transformed plasmid pBAD24; AmpR                                                               study
VDC5241           MG1655 transformed plasmid pBY166; AmpR                                                               study
VDC5333           MG1655 transformed plasmid pYC101.1; AmpR                                                             study
VDC5333           MG1655 transformed plasmid pYC101.4; AmpR                                                             study
VDC5335           MG1655 transformed plasmid pYC102.3; AmpR                                                             study
VDC5336           MG1655 transformed plasmid pYC102.3; AmpR                                                             study
VDC5337           MG1655 transformed plasmid pYC103.1; AmpR                                                             study
VDC5337           MG1655 transformed plasmid pYC103.2; AmpR                                                             study
VDC5339           MG1655 transformed plasmid pYC104.2; AmpR                                                             study
VDC5340           MG1655 transformed plasmid pYC104.4; AmpR                                                             study
VDC5342           MG1655 transformed plasmid pBY167; AmpR
VDC5350           Derivative VDC5217 obtain P1 transduction yrdCEc-1::KmR allele VDC5173;   KmR,   AmpR     study
VDC5351           Derivative VDC5219 obtain P1 transduction yrdCEc-1::KmR allele VDC5173;   KmR,   AmpR     study
VDC5354           Derivative VDC5217 obtain P1 transduction yrdCEc-1::KmR allele VDC5173;   KmR,   AmpR     study
VDC5355           Derivative VDC5219 obtain P1 transduction yrdCEc-1::KmR allele VDC5173;   KmR,   AmpR     study
VDC5358           Derivative VDC5223 obtain P1 transduction yrdCEc-1::KmR allele VDC5173;   KmR,   AmpR     study
VDC5359           Derivative VDC5223 obtain P1 transduction yrdCEc-1::KmR allele VDC517;    KmR,   AmpR     study
VDC5362           Derivative VDC5242 obtain P1 transduction yrdCEc-1::KmR allele VDC5173;   KmR,   AmpR     study
VDC5363           Derivative VDC5242 obtain P1 transduction yrdCEc-1::KmR allele VDC5173;   KmR,   AmpR     study
VDC5366           Derivative VDC5333 obtain P1 transduction yrdCEc-1::KmR allele VDC5173;   KmR,   AmpR     study
VDC5367           Derivative VDC5333 obtain P1 transduction yrdCEc-1::KmR allele VDC5173;   KmR,   AmpR     study
VDC5370           Derivative VDC5337 obtain P1 transduction yrdCEc-1::KmR allele VDC5173;   KmR,   AmpR     study
VDC5371           Derivative VDC5337 obtain P1 transduction yrdCEc-1::KmR allele VDC5173;   KmR,   AmpR     study
Plasmids
pBN200            pET21a:: yrdCEc                                                                                              Study
pBN204            pYES::SUA5; URA3                                                                                             study
pBY125            pBAD24:: ywlCBs cloned NcoI/XhoI fragment; AmpR                                                           study
pBY126            pBAD24:: yrdCEc cloned NcoI/XhoI fragment; AmpR                                                           study
                                                                                 Nucleic Acids Research, 2009, Vol. 37,  9 2897


Table 1. Continued

Strain     Relevant characteristics                                                                                 Reference
                                                                   R
pBY128          pBAD24:: yciOEc cloned NcoI/XhoI fragment; Amp                                                          study
pBY130          pBAD24:: SUA5 cloned NcoI/PstI fragment; AmpR                                                           study
pBY135.1        pYesDEST52:: yrdCEc; AmpR URA3                                                                             study
pBY136.1        pYesDEST52:: yciOEc; AmpR URA3                                                                             study
pBY137.1        pYesDEST52:: ywlCBs; AmpR URA3                                                                             study
pBY138.1        pYesDEST52:: yrdCMm; AmpR URA3                                                                             study
pBY140          pCR2.1::UpyrdCEc; AmpR (999 base pairs upstream region yrdCEc cloned pCR2.1)                      study
pBY141.6        pCR2.1::UpyrdCEc::DnyrdCEc; AmpR (999 base pairs upstream downstream region yrdCEc cloned     study
                  pCR2.1)
pBY146.1        pGEM-T easy:: UpyrdCEc::DnyrdCEc; AmpR                                                                   study
pBY152.1        pGEM-T easy::UpyrdCEc::KmR::DnyrdCEc (DyrdCEC-1::KmR cassette)
pBY166          pBAD24:: ycdCMm; AmpR                                                                                      study
pBY167          pBAD24:: ycdCMm; AmpR                                                                                      study
pYC101.1        Derived site directed mutagenesis pBY126; yrdCEcArg110!Ala; AmpR                                   study
pYC101.4        Derived site directed mutagenesis pBY126; yrdCEcArg110!Ala; AmpR                                   study
pYC102.2        Derived site directed mutagenesis pBY126; yrdCEcArg52!Ala; AmpR                                    study
pYC102.3        Derived site directed mutagenesis pBY126; yrdCEcArg52!Ala; AmpR                                    study
pYC103.1        Derived site directed mutagenesis pBY126; yrdCEcLys50!Ala; AmpR                                    study
pYC103.2        Derived site directed mutagenesis pBY126; yrdCEcLys53!Ala; AmpR                                    study
pYC104.2        Derived site directed mutagenesis pBY126; yrdCEcLys50!Ala; AmpR                                    study
pYC104.4        Derived site directed mutagenesis pBY126; yrdCEcLys50!Ala; AmpR                                    study




YcEcyrdCol3/YcEcyrdCol2; YcEcyciOol1/YcEcyciOol2;                      pET21b (Novagen, , Madison, WI) using NdeI YcMmyrdcol1/YcMmyrdCol2;                    YcBsywlCol1/               XhoI.
YcBsywlCol2; sequenced recombination pYES-DEST52 (carrying URA3 gene selection                   Construction E. coli DyrdCEc-1::KmR allele
Â—ura media) (Invitrogen) using Gateway LR Clonase                  Fragments upstream (908 bp) downstream (991bp) Enzyme Mix according manufacturer protocol.                        yrdCEc PCR ampliï¬?ed E. coli MG1655 genomic
Plasmids transformed yeast strains according              DNA using US71_ol1 UP979_ol2, DS1561_ol1 manufacturer protocol (Invitrogen, Carlsbad, CA).                  DS2552_ol2, respectively. subcloning purposes,
Transformants screened SD -ura plates                      DS1561_ol1 DS2552_ol2 contained NotI checked presence orthologous gene trans                  XhoI restriction sites respectively. yrdCEc upstream PCR using gene-speciï¬?c primers used cloning.                fragment (UpyrdCEc) cloned pCR2.1-TOPO
   cloning pRS313 (28), primers CENupsua5.ol1                 (Invitrogen, Carlsbad, CA). resulting plasmid CENdnsua5.ol2 used amplify SUA5 gene                   pCR2.1::UpyrdCEc (pBY140) checked orientation. yeast 272 bp upstream region 124                yrdCEc downstream fragment (DnyrdCEc) bp downstream region (UpSUA5Dn). upstream                       digested NotI XhoI ligated pBY140
region designed based previous data showing                     digested enzymes plasmid presence 190 bp fragment upstream                     pBY141.6. Upstream::Downstream fragment SUA5 suï¬ƒcient drive gene expression (4). PCR                 pBY141.6 subcloned pGEM-T easy vector
product cloned pCR-Blunt TOPO (Invitrogen,                    (Promega) using ApaI SacI sites, resulting
Carlsbad, CA) yielding pBY168.6. checking                     plasmid pBY146.1 digested EcoRV site
sequencing, UpSUA5Dn cloned pRS313                        present upstream downstream frag-
using EcoRI restriction site ï¬‚anking insert                 ments used clone KmR cassette (containing
pCR-Blunt EcoRI site pRS313. resulting                  FRT sites) ampliï¬?ed pKD4 (29)
plasmid, pBY176.3 (pRS313::UpSUA5Dn), allows SUA5                      using FRTKn_ol1 FRTKn_ol2 primers. expressed native promoter used             resulting     plasmid      pGEM-T         easy::UpyrdCEc::
complementation purposes.                                              KmR::DnyrdCEc (pBY152.1) used template
   construction pBN204, yeast SUA5 gene                 generate PCR UpyrdCEc::KmR::DnyrdCEc
ampliï¬?ed using forward primer BN1 reverse primer                   deletion cassette used replacement yrdCEc.
BN2 plasmid pM249 (4). forward primer                         Induction  recombination functions preparation
included yeast initiation sequence AAUA                      NM1100/pBAD24::yrdCEc, NM1100/pBAD24::yciOEc,
BamHI site. reverse primer included XhoI site.                  NM1100/pBAD24 competent cells sites used ligate DNA fragment                 described (30). electroporation, cells plated
pYES2 (URA3) (Invitrogen) generate pBN204.                      LB Km supplemented 0.02  arabinose. Km resis-
construction pBN200, yrdCEc ampliï¬?ed geno-                 tant colonies isolated twice checked gene
mic DNA using primers BN3 BN4 cloning                  replacement using Km-speciï¬?c primers [k1 k2, (29)]  2898 Nucleic Acids Research, 2009, Vol. 37,  9


Table 2. Primers used study

Primer                                                  Primer sequence

BADBsywlCol1                                                 CCATGGAAACGAAAAGATGGTTT
BADBsywlCol2                                                 AAGCTTTCAGCGAATCACTCTTCCTCC
BADEcyciOol1                                                 CCATGGGCCAGTTTTTTTATATTCAT
BADEcyciOol2                                                 AAGCTTTTATAAGAAAGGCTTCACATCAC
BADEcyrdCol1                                                 CCATGGATAATAACCTGCAAAGAGA
BADEcyrdCol2                                                 AAGCTTTTACCCCTGTCGAAACAGTTC
BADMmyrdCol1                                                 CCATGGAAACTTTCGAGATTTCAGAAA
BADMmyrdCol2                                                 AAGCTTTTATTCATTTACTGCTTTTAAAATCTC
BADsua5ol1                                                   CCATGGACCTTGGACGACATTTTTT
BADsua5ol2                                                   CTGCAGTTAAAACTGTATACAATTATTTGCAG
YcMmyrdcol1                                                  CACCATGAAAACTTTCGAGATTTCAGAAAGT
YcMmyrdCol2                                                  TCATTATTCATTTACTGCTTTTAAAATCTC
YcBsywlCol1                                                  CACCATGAAAACGAAAAGATGGTTTGTG
YcBsywlCol2                                                  TCAGCGAATCACTCTTCCTCCGG
YcEcyciOol1                                                  CACCATGAGCCAGTTTTTTTATATTCATC
YcEcyciOol2                                                  TCATTATAAGAAAGGCTTCACATCAC
YcEcyrdCol1                                                  CACCATGAATAATAACCTGCAAAGAGA
YcEcyrdCol3                                                  TCATTACCCCTGTCGAAACAGTTCA
CENupsau5.ol1                                                GGTACCTATTTCGTTGAAAAATTCAGGC
CENupsau5.ol2                                                GGTACCGTATGGGCGACTTTTCGTAT
BN1                                                          CGGCGCTCCAAUAATGTACCTTGGACGACATTTTTTGGCA
BN2                                                          CGACCAATGCTCGAGTTAAAACTGTATACAATTATTTGCAGC
BN3                                                          CAG CCG CAT ATG AAT AAT AAC CTG CAA AGA GAC GC
BN4                                                          GCC TCG CTC GAG CCC CTG TCG AAA CAG TTC ACC CG
US71_ol1                                                     ACA ATG CCC TGC TAT GGC TG
US979_ol2                                                    GTT ATT ATT CCG CCG AAA CCG
DS1561_ol1                                                   TTA GCG GCC GCC GAC AGG GGT AAC ATA ATG G
DS2552_ol2                                                   TTA CTC GAG GCG ATG CTG ACG AAA ACT CG
FRTKnol1                                                     GTGTAGGCTGGAGCTGCTTC
FRTknol2                                                     CTTAGTTCCTATTCCGAAGTTC
sua5::Leu.ol1                                                TTT CGT TGA AAA ATT CAG GC
sua5::Leu.ol3                                                GGG CGA CTT TTC GTA TAT ACA
Upleu2_ol1                                                   AGA TCT CAC ACA GGG GCG CTA TCG C
Dsleu2_ol2                                                   AGA TCT TAT AAA GTT TAT GTA CAA ATA TCA
Chksua5leuol4                                                TTG CCA ATA CAA CAT AAC CG
Chksua5leuol5                                                GTT ATT GCT CAT CAG CAG TA
EcyrdCLys50Ala.ol1                                           ACTGTTGGAGTTAGCGCAGCGTCCGGTTG
EcyrdCLys50Ala.ol2                                           CAACCGGACGCTGCGCTAACTCCAACAGT
EcyrdCLys56Ala.ol1                                           CAGCGTCCGGTTGATGCGGGGCTGATTTTAATC
EcyrdCLys56Ala.ol2                                           GATTAAAATCAGCCCCGCATCAACCGGACGCTG
EcyrdCArg52Ala.ol1                                           GAGTTAAAACAGGCGCCGGTTGATAAGGGGC
EcyrdCArg52Ala.ol2                                           GCCCCTTATCAACCGGCGCCTGTTTTAACTC
EcyrdCArg110Ala.ol1                                          CTGGTTGACGGGCGCGTTTGATTCGCTTGCTG
EcyrdCArg110Ala.ol2                                          CAGCAAGCGAATCAAACGCGCCCGTCAACCAG
Leucassol3                                                   AGT CAT CGA ATT TGA TTC TG



combination upstream downstream primers             sua5leu.ol3 primers. :sua5-D1::Dn::LEU2 PCR
(UP71_ol1 DN2552_ol2) described text.          product used transform yeast cells. Transformants
                                                             plated SD Gal/Raf -leu veriï¬?ed PCR. Construction sua5-D1::LEU2 allele                     cure URA3 marker containing plasmids (plasmid
                                                             derived pYES-DEST52 pYES2), 10 ml serial
Primers sua5leu.ol1 sua5leu.ol3 used amplify     dilutions yeast liquid cultures grown SD Gal/Raf -leu 1671 bp fragment encompassing SUA5. fragment          spotted diï¬€erent types plates. Plates cloned pGEMT easy (Promega, Madison, WI)            containing SD Gal/Raf -ura -leu medium check yielding pBY154. BglII site exists ampliï¬?ed     presence expected markers 5-FOA medium
fragment used deletes 1000 bp        (SD Gal/Raf supplemented 50 mg/ml uracil ampliï¬?ed fragment, retaining, 225 bp homology       0.1  5-FOA) select yeast cells did retain region 50 (56 56 ï¬?rst bp     URA3 carrying plasmid  presence URA3 gene
SUA5) 323 bp homology 30  leucine       5-FOA toxic (31)].
cassette ampliï¬?ed wild-type BY4743 genomic
DNA using primers UPleu.ol1 DNleu.ol2                                                              Construction point mutantions yrdCEc contained BglII sites ligated pBY154 diges-
                                                             site-directed mutagenesis
tion vector insert BglII. resulting
plasmid, pBY164 used template amplify            Plasmid pBY126 (pBAD24::yrdCEc) used tem- sua5-D1::Dn::LEU2 cassette using sua5leu.ol1          plate mutagenesis. Primer pairs EcyrdCLys50Ala.
                                                                         Nucleic Acids Research, 2009, Vol. 37,  9 2899


ol1/EcyrdCLys50Ala.ol2, EcyrdCArg52Ala.ol1/EcyrdCA              B 5 min, 50Â—75  B 4 min stay 75  B rg52Ala.ol2, EcyrdCLys53Ala.ol1/EcyrdCLys53Ala.ol2              3 min, 75Â—100  B 8 min. column EcyrdCArg110Ala.ol1/EcyrdCArg110Ala.ol2,               washed 100  B 7 min equilibrated used mutate Lysine position 50, Arginine position      100  10 min. ï¬‚ow rate used 1 ml/min.
52, Lysine position 53  Arginine position 110         Chromatography performed room temperature. Alanine. Mutagenesis performed described         elution nucleosides followed UV detection QuickChangesTM Site Directed Mutagenesis Kit           254 nm. HPLC coupled hybrid triple
(Stratagene, La Jolla, CA). plasmids checked        quadrupole-ion trap (4000 Q-TRAP, Applied Biosystems,
sequencing.                                                     Foster City, CA, USA) mass spectrometer equipped                                                                 TurboIonSpray (TIS) interface operated positive
Growth curves                                                   ion mode. ESI parameters  curtain gas (CUR) Growth curves performed using Bioscreen C MBR            30 psi, ion source   5000V, nebulizer gas (GS1) (Oy Growth Curves AB  Finland) 30 max-           45 psi, TIS gas (GS2) 45 psi TIS probe temper-
imum shaking. 300 ml culture used       ature 300 C. information-dependent acquisition
10 replicates used condition. Yeast cultures      (IDA) mode operation employed grown SD Gal/Raf  saturation diluted 200         survey scan m 100Â—600 acquired followed times SD Gal/Raf  loading Bioscreen.       collision-induced dissociation (CID) growth curves presented representative 10            intense ions. Survey MS/MS spectra ï¬?ve
replicates.                                                     IDA cycle accumulated 1 s 3 s, respectively.
                                                                tRNA extractions analysis performed Puriï¬?cation bulk tRNA                                        twice independently. E. coli derivatives, 1 liter cultures grown    HPLC analysis
night 37 C LB media supplemented ampicillin
(50 mg/ml) arabinose required, harvested,          digestion, samples immediately used analy- stored Â—20 C. cell pellets defrosted      sis HPLC.  100 ml digested sample resuspended 20 ml buï¬€er (10 mM Tris, 10 mM                added glass HPLC micro-vial run using
MgCl2, pH 7.4). yeast cultures, 2 l cell cultures        250 mM ammonium acetate pH 6 (Organic Solvent  grown saturation 30 C, harvested pellets        40  Acetonitrile (Aqueous Solvent B). Samples run
immediately resuspended 20 ml buï¬€er (10 mM Tris,          60 min ï¬‚ow rate 1.5 ml/min Suppleco
10 mM MgCl2, pH 7.4). cases, homogenate             Discovery C-18 Reverse Phase column (15 cm  4.6 mm treated buï¬€er-saturated phenol, pH 7.4                  5 um) (Suppleco 504955) detected Waters 2487
(Sigma), aqueous layer collected phenol       Dual Wavelength UV/Vis detector. Samples injected
extraction step, RNA precipitated etha-        Waters 717 plus Autosampler, pumped nol. bulk tRNA puriï¬?ed Nucleobond               Waters 1525 Binary Pump Waters Inline
AX-400 columns (Clontech Laboratories, Mountain                 Degasser. Analysis Waters Breeze Software
View, CA) (according manufacturerâ€™s protocol)            v3.20. method used linear gradient consisting precipitated isopropanol.                              98  solvent 2  solvent B start ï¬‚ow rate
                                                                1.5 ml/min, decreasing 80  20  B 60 min
HPLC separation coupled electrospray tandem mass           change ï¬‚ow rate.
spectrometry analysis digested bulk tRNA
                                                                Preparation tRNAThr compare nucleoside constituents bulk tRNA
puriï¬?ed diï¬€erent strains, samples              plasmid containing E. coli tRNAThrCGU gene
puriï¬?ed bulk tRNA preparation enzymatically                thrW kind gift Dr Waas  Scripps Research
hydrolyzed described Pomerantz et al. (32)                Institute). tRNAThrCGU overexpressed MRE600
Approximately 100 mg bulk tRNA digested             cells induced isopropyl-b-D-thiogalactoside (IPTG,
10 units Nuclease P1 (Sigma), 0.01 units                  0.5 mM, 37 C, 12 h) LB-Amp (100 mg/ml). har-
Phosphodiesterase (Sigma) 3 ml E. coli Alkaline        vested cells lysed buï¬€er (0.3 M NaOAc, pH 5.2,
Phosphatase (Sigma P4252) total volume 113 ml.          10 mM EDTA) subjected phenol extraction (pH digested extracts lyophilized resuspended       4.5) ethanol precipitation. tRNAThr partially pur-
20 ml water. resuspended tRNA degradation                iï¬?ed total nucleic-acid extract Nucleobond
extracts injected LCÂ—MS/MS sepa-           column (Clontech Laboratories, Mountain View, CA)
ration identiï¬?cation nucleosides. C18-RP           using manufacturer protocols, precipitated isopropy-
(Gemini 5m, 250  4.6 mm, Phenomenex, Torrance, CA,             lalcohol (100 , room temperature), washed ethanol
14 USA) analytical column used, C18 cartridge        (80 , Â—20 C), dissolved water, point prolong lifetime. mobile phase consisted      80  pure. tRNAThr puriï¬?ed C4
solvents: 250 mM ammonium acetate pH6.0 solvent          reverse-phase preparative column pre-equilibrated 40  acetonitrile solvent B. gradient used         buï¬€er (10 mM sodium phosphate pH 5.5, 1 M sodium nucleoside separation performed previously           formate, 8 mM MgCl2) eluted 60-min 0Â—40 
described (32). consisted elution gradient      gradient buï¬€er B (10 mM sodium phosphate pH 5.5,
eral steps: 0Â—5  B 7 min, 5Â—10  B 15 min, 25Â—50           10  methanol). tRNA eluted equal-sized
 2900 Nucleic Acids Research, 2009, Vol. 37,  9


peaks. assaying fractions threonine accep-       ï¬‚uorescence signal taken 3-min incu-
tance E. coli threonyl-tRNA synthetase using stan-     bation period step allow complete binding.
dard aminoacylation assay described (33),          correct dilution eï¬€ects, titration peaks contain tRNAThr >97  purity.           repeated addition incremental
Treatment base (pH 8.5) pooled sample          volumes water. readings corrected buï¬€er peaks yielded separate peaks ana-        absorption need inner ï¬?lter correction (absor-
lytical reverse-phase chromatography, indicating     bance 295 nm tRNA highest concentration species correspond diï¬€erent aminoacylation      0.05). Theoretical curves ï¬?tted exper-
states. Fractions peaks pooled separately    imental data dissociation constants determined tRNA precipitated, washed twice cold etha-       according following equation (36):
nol, dissolved water. MALDI-TOF mass spec-                          0                                     1
trometry analysis ï¬?nal tRNA peaks                               Ã°Kd Ã¾ P0Ã¾ N0 Ãž                    
revealed molecular masses 24 540 24 686 Da.                      B aqrt Ã°Kd Ã¾ P0 Ã¾ N0 Ãž2  Ã°4P0 N0 Ãž C
                                                                 Â¼ 1 Ã¾ Ã°f  1ÃžB
                                                                              @
                                                                                                                    C
                                                                                                                    mass diï¬€erence accounted molecular mass      I0                                2P0
carbamoyl-threonine (145.12 Da).
   tRNAThr transcript synthesized standard T7
polymerase transcription (34) linearized DNA tem-        I0 corrected ï¬‚uorescence intensities
plate [pUC18; (35)] containing E. coli tRNAThrCGU         protein proteinÂ—tRNA complex, respectively. P0
gene thrW (kind gift Dr K. Beebe, Scripps              N0 total concentrations protein Research Institute). phenolÂ—chloroform extraction       tRNA, respectively, f ï¬‚uorescence intensity ratio reaction, RNA ethanol precipitated,            bound free protein, Kd dissociation dissolved water puriï¬?ed anion-exchange           constant.
high-performance liquid chromatography heated
(90 C) preparative DNA-Pac column (Dionex,                   Detection ATP binding STD-NMR
Sunnyvale, CA) according standard protocols (34).          NMR experiments performed 278K Varian single tRNAThr eluant pooled, ethanol precipi-        INOVA 600 NMR spectrometer equipped 5 mm
tated, suspended water assayed threonine        triple resonance inverse detection probe. Samples acceptance. Final purity >95  10  urea PAGE            prepared 500 ml 99  D2O PBS buï¬€er pH 7.5
analysis. ï¬?nal tRNA samples prepared             (uncorrected) containing 10 mM phosphate, 137 mM
binding studies heating 90 C slow-cooling          NaCl, 2.7 mM KCl, 0.5 mM MgCl2 0.02  NaN3. addition 5 mM MgCl2 ensure proper                 Concentration NMR sample 20 mM protein
folding.                                                      1 mM ligand. STD pulse sequence implemen-
                                                              ted suggested (37), minor variations. exci-
Overexpression puriï¬?cation E. coli YrdC            tation train composed 50 ms G4 composite pulses
protein (YrdCEc)                                              1 ms delay pulses. resonance oï¬€-
E. coli BL21(DE3) cells transformed pET21         resonance irradiations centered Â—1 ppm derivative (Novagen) vector containing E. coli yrdC       30 ppm, respectively, total saturation time gene (pBN200). protein overexpressed induc-        3 s. Initial FIDs multiplied line broadening
tion 1 mM IPTG LB medium containing 100 mg/ml         function 1 Hz zero ï¬?lled twice original
Amp. Cells harvested lysed buï¬€er (20 mM           data size prior Fourier transformation. total 512
Tris, 500 mM NaCl, 28 mM imidazole, 1 mM b-mercap-            scans 16 dummy scans acquired, recycle
toethanol protease inhibitor cocktail). protein       delay 2 s. puriï¬?ed Ni-NTA aï¬ƒnity chromatography,
dialyzed phosphate-buï¬€ered saline concen-
                                                              RESULTS
trated using YM-3 Centriprep ï¬?lter (Millipore Corp.,
Billerica, MA).                                               Involvement Sua5/YrdC family proteins
                                                              t6A formation
Measurements YrdCEc binding tRNA Trp
                                                              Bioinformatic identiï¬?cation. Analysis sequenced
ï¬‚uorescence quenching
                                                              tRNAs (38) suggested organisms used steady-state techniques monitor changes     t6A biosynthesis pathway. Using MGDB database
intrinsic ï¬‚uorescence tryptophan chains    (http://mbgd.genome.ad.jp/), list orthologous families
positions 89 106) E. coli YrdC addition        present E. coli K12, S. cerevisiae, B. subtilis 168,
tRNA previously described (2). Using Jobin Yvon          Buchnera aphidicola APS, Wigglesworthia glossinidia,
FluoroMax-3 spectroï¬‚uorometer (Edison, NJ),              Wollbachia endosymbiot mel mollicutes cell compartment kept constant temperature             database (16 genomes) generated. analysis 21 C, ï¬‚uorescence signal (lex = 295 nm;               revealed existence 95 orthologous protein families,
lem = 345 nm) free YrdC (2 mM 20 mM HEPES,              related translation (ribosomal protein, tRNA
100 mM NaCl, pH 7.5) taken. Deï¬?ned volumes           synthetases tRNA modiï¬?cation). concentrated aqueous solution tRNA added         families did experimentally veriï¬?ed function steps ï¬?nal tRNA concentrations 0.05Â—3.50 mM          work initiated                                                                                       Nucleic Acids Research, 2009, Vol. 37,  9 2901




Figure 1.   Schematic representation YrdC/Sua5 family. YrdC E. coli 192 amino acids, yeast Sua5 420 amino acids human IRIP 279 amino acids 1Â—55 mitochondrial signal peptide. position KxR(50)SxN conserved motif given E. coli sequence. (B) Sequence alignment YrdC domain YrdC Sua5 family proteins E. coli YrdC, S. tokodaii Sua5 E. coli YciO
sequences aligned based 3D alignment crystal structures. Secondary structure elements crystal structure E. coli YrdC shown sequences. Red boxes indicate conserved residues YrdC YciO families. Residues interact bound AMP S. tokodaii Sua5 crystal structure indicated red black stars. K50 R52, mutated present study used distinguish YciO YrdC families, indicated red stars. S107, residue mutated yeast sua5-1 mutant indicated #. Ec: E. coli,
Mm: M. maripaludis, Bs: B. subtilis, St: Sulfolobus tokodaii, Sc: S. cerevisiae.


functionally characterized  YrdC/Sua5                            enzyme family HypF (2) [involved maturation
(Figure 1A) family probable candidate                     metal center Ni-Fe hydrogenase HypE (39)] enzyme involved t6A biosynthesis following                   catalyzes chemistries similar ones expected reasons:   organisms sequenced date homo-                  t6A biosynthesis (22); (iii) YrdC YciO E. coli log YrdC/Sua5 proteins, organisms,                     bind double-stranded RNA tRNA (2);
E. coli, representatives (YrdC YciO),                     (iv) Sua5 yeast proposed involved transla-  (ii) YrdC domain                     tion (4).
 2902 Nucleic Acids Research, 2009, Vol. 37,  9




Figure 2.   LCÂ—MS/MS analysis yeast tRNA extracted diï¬€erent strains linking disappearance t6A peak deletion sua5.
UV traces ion extraction chromatograms 413 m (small windows) shown WT (YMH13) upper panels, sua5::LEU2 (YJN63) middle
panels YGN63 transformed pBN204 (SUA5 URA3) lower panels. (B) Complementation t6A minus phenotype followed HPLC
analysis bulk yeast tRNA extracted various strains. position t6A peak conï¬?rmed running t6A standard spiking WT sample (data shown). Strain YGN63 transformed URA3 plasmids carrying SUA5  control) carrying wild-type genes yrdCEc,
yciOEc ywlCBs, respectively recovery t6A peak monitored. (C) LCÂ—MS/MS analysis yeast tRNA extracted sua5::LEU2 yrdCMm strain. UV traces ion extraction chromatograms 413 m (small windows) shown. Positive negative controls run presented   (data shown).

 vivo experimental validation. order examine                  wild-type genes: yrdCEc (pBY135.1), yciOEc (pBY136.1),
t6A phenotype  e. presence absence t6A modiï¬?ca-                   ywlCBs (pBY137.1) yrdCMm (pBY138.1). Bulk tRNA
tion RNA) strains lacking members SUA5/                      extracted analyzed check presence
yrdC gene family existing strain, YJN63 (sua5::LEU2)                   t6A transformed strains. genes excep-
(4), carries deletion allele SUA5 analyzed.                tion yciOEc, able complement t6AÂ— pheno-
Bulk tRNA extracted YGN63 near                        type YJN63 (Figure 2B C).
isogenic wild-type strain YMH13 (SUA5) (4) pro-
cessed LCÂ—MS/MS analysis described                          Essentiality yrdC orthologs
â€˜Materials Methodsâ€™ section. analysis revealed                   Essentiality S. cerevisae SUA5 wild-type gene. order 25.5 min peak detected UV trace                    clarify contradictory data essentiality parent strain, corresponding protonated molecular                  SUA5, replacement wild-type allele weight t6A (MH+= 413m , disappeared strain                    sua5-D1::LEU2 cassette attempted diï¬€erent
carrying sua5::LEU2 allele (Figure 2A). t6A peak                  backgrounds  â€˜Material Methodsâ€™ section  recovered strain transformed                     struction details): diploid, BY4743 (SUA5/SUA5
plasmid carrying wild-type SUA5 gene (plasmid                         ura3D0/ura3D0 leu2-D0/leu2-D0), haploid BY4741
pBN204) conï¬?rming t6AÂ— phenotype (absence                        (SUA5 ura3D0 leu2-D0) VDC5309 (SUA5 yrdCEc t6A peak) loss SUA5 (Figure 2A).                     URA3 ura3D0) strain BY4741 transformed    determine sua5 homologs actual func-                   yrdCEc URA3 carrying plasmid (pBY135.1). Leu+
tional orthologs, E. coli, B. subtilis M. maripaludis                 clones obtained backgrounds, 
yrdC-like genes tested ability complement               analyzed PCR, clones derived t6AÂ— phenotype sua5::LEU2 strain. YGN63                    diploid BY4743 merodiploid VDC5309 carried
transformed URA3 plasmids carrying following                     sua5-D1::LEU2 marker right locus, yielding
                                                                                      Nucleic Acids Research, 2009, Vol. 37,  9 2903




Figure 3.   PCR ampliï¬?cation conï¬?rm presence correct location sua5-D1::LEU2 allele various yeast strains. Lanes 1, 3 5:
primers Chksua5leu.ol4 Chksua5leu.ol5 lanes 2, 4 6: primers Chksua5leu.ol4 Leucassol3. Strains VDC5417 (BY4741 derivative
SUA5 LEU2 URA3 yrdCEc) lanes 1/2; VDC5300 (BY4743 derivative (SUA5/sua5-D1::LEU2) lanes 3/4; VDC5416 (BY4741 derivative sua5-
D1::LEU2 yrdCEc) lanes 5/6. Strains tested primer combinations. VDC5417 cassette inserted ectopically, e. Leu+ negative PCR tests using Chksua5leu.ol4/Leucassol3 primer set. VDC5033 VDC5416 insertion cassette correct
location conï¬?rmed. Expected sizes  750 bp sua5-D1::LEU2 allele right locus using Chksua5leu.ol4/Leucassol3 combination 2300 bp wild-type allele SUA5 2800 bp sua5-D1::LEU2 allele using Chksua5leu.ol4/Chksua5leu.ol5 primer combination.
Annealing positions primers used shown panel  relevant genotypes shown, refer Table 1 completeness. (B)
FOA curing pBY135.1 (URA3 yrdCEc) strains VDC5300 (SUA5/sua5-D1::LEU2), VDC5417 (SUA5 LEU2 URA3 yrdCEc) VDC5416
(sua5-D1::LEU2 yrdCEc). 20 ml serial dilutions saturated cultures VDC5416, VDC5417 VDC5300 replica-plated SD Gal/Raf -ura
-leu FOA plates analyzed 5 days. Strains carrying URA3 marker unable grow 5-FOA. VDC5300 used control auxotrophies. (C) Veriï¬?cation cured strains PCR using plasmid speciï¬?c primers DEST52.ol1 DEST52.ol2: lane 1, VDC5417; lane 2,
VDC5416; lane 3 4 corresponding respective FOA treated derivatives.


SUA5/sua5-D1::LEU2 sua5-D1::LEU2 yrdCEc deriva-                        background (Figure 3B). curing pBY135.1
tives, respectively (Figure 3A). haploid background                 sua5-D1::LEU2 genotype conï¬?rmed BY4741, ectopic insertion cassette occurred yielding                PCR (Figure 3C) plating SD Gal/Raf agar
SUA5 LEU2 strains, correct insertion dele-                   plates lacking uracil/leucine leucine (data tion cassette obtained.  SUA5                  shown). results showed SUA5 gene disrupted backgrounds functional copy                           essential yeast conï¬?rming results previous study
remained present genome, suggesting SUA5                       (4). analysis growth phenotype essential gene yeast, agreement                   sua5-D1::LEU2 strains conï¬?rmed growth defect phe-
result systematic yeast gene deletion study (11).                   notypes observed FOA plates. Growth experiments    order demonstrate essentiality                     YPD dramatic decrease growth rate cured
SUA5, attempts dissociate sua5-D1::                       strain VDC5440 compared haploid parent strain
LEU2 allele URA3 yrdCEc plasmid pBY135.1.                         BY4741 (Figure 4A). plasmid carrying SUA5 SUA5 essential plasmid cur-                   control endogenous promoter region
able VDC5416 (sua5-D1::LEU2 pBY135.1),                       (pBY176.3) complemented t6A deï¬?ciency readily lost VDC5417 (SUA5 LEU2                             VDC5440 slow growth phenotype (Figure 4B
pBY135.1). URA3 allele carried plasmid                    C), conï¬?rming secondary
confers sensitivity 5-FOA, strains tested                mutation. results gene ability grow presence compound. Culture                  modiï¬?cation essential yeast. failure dilutions VDC5416 plated 5-FOA medium                       obtain haploid mutant direct transformation resulting growth phenotype compared                     likely reduced growth phenotype.
control strains: VDC5417 carrying ectopic insertion deletion cassette heterozygote VDC5300                         Essentiality E. coli yrdC. test yrdCEc
(SUA5/sua5-D1::LEU2 ura3D0/ura3D0). Derivatives                            gene essential E. coli, similar approach control strains grew presence 5-FOA                     employed yeast followed. Homologous
expected. prolonged incubation, 5-FOAR derivatives                   replacement wild-type yrdC allele yrdCEc- sua5-D1::LEU2 pBY135.1 recovered suggest-                     1::KmR allele attempted direct transformation ing pBY135.1 eliminated                            UpyrdCEc::KmR::DnyrdCEc PCR generated fragment
 2904 Nucleic Acids Research, 2009, Vol. 37,  9




Figure 4.   Growth phenotype VDC5440 (sua5-D1::LEU2 ura3D0) compared WT parent BY4741 (B) Growth phenotype VDC5440 transformed plasmid pRS313 carrying SUA5 control endogenous promoter region (pBY176.3) plasmid
control pRS313 SD Gal/Raf   growth experiments performed 30 C. Shown representative plots replications. (C)
LCÂ—MS/MS analysis tRNA extracted yeast strains showing absence presence t6A peak UV trace (left  extraction chromatogram (right  VDC5440 transformed pBY176.3 (upper panels) VDC5440 transformed pRS313 (lower
panels).

 diï¬€erent backgrounds: E. coli NM1100,                            P1 transduction following strains used NM1100/pBAD24               NM1100/pBAD24::yrdCEc                       recipients: MG1655 transformed pBAD24 deriva-
(pBY126)  â€˜Material Methodsâ€™ section),                          tives carrying functional yrdC homologs, yrdCEc, strain contains functional copy yrdCEc                     ywlCBs, yrdCMm SUA5Sc (pBY126, pBY125, pBY167
plasmid. Km resistant clones insertion                          pBY130 respectively) carrying non-functional
marker expected location  veriï¬?ed PCR)                         homolog yciOEc (pBY128). P1 transductions carried obtained NM1100/pBAD24::yrdCEc                           ï¬?ve times independent MG1655  backgrounds suggesting chromo-                       grounds ortholog, Km-resistant colonies somal copy gene eliminated func-                  recovered backgrounds  variation tion insured gene trans (Figure 5A).                             120Â—500 colonies transduction) MG1655/
   essentiality yrdCEc demonstrated                   pBAD24 MG1655/pBAD24::yciOEc P1 transduction experiments. Strain VDC5173 (NM1100                         yielded colonies  non-essential markers yrdCEc-1::KmR/pBAD24::yrdCEc) used donor                        readily transduced strains). data conï¬?rm
                                                                                   Nucleic Acids Research, 2009, Vol. 37,  9 2905




Figure 5.   PCR ampliï¬?cation conï¬?rm presence yrdCEc-1::KmR allele kanamycin-resistant NM1100/pBAD24::yrdCEc derivatives. independent KmR strains (VDC5173, lanes 1, 4 7 VDC5174 lanes, 2, 5 8) obtained transformation NM1100/
pBAD24::yrdCEc PCR generated yrdCEc-1::KmR cassette NM1100/pBAD24::yrdCEc background strain (lanes, 3, 6 9) subjected PCR analysis using primer combinations UpyrdC/K2 (lanes 1, 2 3), DsyrdC/K1 (lanes 4, 5 6) UpyrdC/DnyrdC (lanes
7, 8 9). expected sizes UpyrdC/DsyrdC amplicons WT mutant strains 2340 3113 bp respectively, DsyrdC/K1 UpyrdC/K2 ampliï¬?cation NM1100 control. (B) Growth phenotype MG1655 yrdCEc-1::KmR P1 transductants. Strains streaked LB Amp plates supplemented 0.02  arabinose incubated 24 h 37 C. MG1655/pBAD24 used control.


 yrdCEc essential gene E. coli strains                 apparently non-speciï¬?c binding YrdC MG1655 NM1100, supports result obtained                     unmodiï¬?ed vitro transcript tRNAThr yeast, SUA5, yrdCEc, yrdCMm, ywlCBs                  detected. results suggest YrdC involved functional orthologs yciOEc  pBAD                    t6A biosynthesis interacting directly tRNAs, 
struct places genes control arabinose               sistent previously reported binding YrdC inducible promoter orthologs, SUA5Sc                  total tRNA (2). proï¬?cient replacing yrdCEc gene. absence inducer, E. coli strain carrying                     Binding YrdCEc ATP. t6A biosynthesis crude
yrdCEc-1/pBY130 (pBAD24::SUA5) showed delayed                        enzyme preparations shown require ATP
growth phenotype observed strains carrying                  (22) Sua5St ortholog Sulfolobus tokodaii genes (Figure 5B).                                          recently bind hydrolyze ATP
   Analysis bulk tRNA extracted classes                (41). investigate YrdCEc speciï¬?cally bind P1 transductants obtained showed contained                  ATP, screened various nucleotides potential
t6A indicating orthologs complement                 bind YrdC saturation-transfer diï¬€erence NMR
essentiality tRNA modiï¬?cation phenotypes (data                  (STD-NMR) spectroscopy. strong STD-NMR signal
shown).                                                                 seen ATP ADP CTP                                                                         UTP, indicating adenine-speciï¬?c binding (Figure 6B),
                                                                        pointing presence ATP-binding
Direct involvement YrdC t6A biosynthesis
                                                                        sites YrdCEc.
Preferential binding YrdCEc apomodiï¬?ed
tRNAThr. investigate members YrdC/                    Essentiality E. coli YrdC conserved residues Arg52 Sua5 family act directly tRNA t6A biosynthesis,                   Lys50. Arg52 Lys50 residues strictly conserved
YrdCEc binding tRNA species known contain                       YrdC proteins absent YciO pro-
t6A E. coli, tRNAThr, tested. forms                     teins (Figure 1B). residues located center E. coli tRNAThrCGU generated; vivo expressed                positively charged cleft putative nucleic-acid-
forms vitro transcribed form lacked                 binding site, based crystal structure post-transcriptional modiï¬?cations. seen previously                S. tokodaii protein Sua5St, chains (Arg59 investigators (40), overexpression tRNAThr pro-                Lys57 using S. tokodaii residue numbering) interact duced forms diï¬€er exact molecular mass               stabilize AMP derived phosphate group carbamoyl-threonine suggesting diï¬€er                   bound cleft. (41). suggested nucleotide
presence absence modiï¬?cation nucleotide                   binding YrdC Sua5 (41) critical function.
37. forms aminoacylated ThrRS similar                 test functional signiï¬?cance residues
degrees indicating properly folded, func-                vivo, site-directed mutagenesis used construct
tional tRNAs. Fluorescence quenching data                     E. coli strain MG1655 carrying pBAD24 plasmids harbor-
YrdC binds fully modiï¬?ed tRNAThr partially                    ing yrdCEc Lys50 ! Ala Arg52!Ala, yrdCEc
modiï¬?ed tRNAThr (lacking threonyl-carbamoyl                    Arg110!Ala Lys53!Ala control (pYC102.3,
modiï¬?cation) estimated dissociation constants                   pYC104.2, pYC101.1 pYC103.1, respectively). 0.62 Â± 0.13 0.11 Â± 0.05 mM, respectively, indicating                used P1 experiments recipient strains high binding aï¬ƒnity (Figure 6A). weak                          described earlier. clones  2906 Nucleic Acids Research, 2009, Vol. 37,  9




Figure 6.   YrdC binding tRNAThr measured intrinsic ï¬‚uorescence quenching assay. Relative Trp ï¬‚uorescence intensity YrdC function partially modiï¬?ed vivo expressed tRNAThr lacking t6A37 modiï¬?cation (ï¬?lled square), fully modiï¬?ed vivo expressed tRNAThr
(ï¬?lled circle) unmodiï¬?ed tRNAThr transcript (ï¬?lled triangle). Sample conditions: 2 mM protein, 20 mM HEPES, pH 7.5, 100 mM NaCl, 20 C.
lex = 295 nm, lem = 345 nm. (B) STD-NMR spectra nucleotides presence E. coli YrdC. nucleotides ATP, ADP, CTP UTP traces shown, lower trace reference 1D NMR spectrum, upper trace STD spectrum obtained irradiation aliphatic region YrdC. Ligand binding indicated positive signals STD spectrum, particularly strong H8, H2 H1 resonances ATP ADP 6Â—8 ppm region. Little binding observed CTP UTP.



recovered P1 experiments control strain                      concave surface crystal structure YrdC MG1655pyrdCEc, MG1655pyrdCEc Arg110!Ala                                 strictly conserved YrdC subfamily absent MG1655pyrdCEc Lys53!Ala used recipients,                           YciO sequences (Figure 1B). residues essential transductants recovered MG1655/                       YrdC function shown site directed mutagenesis
pYC104.2 MG1655/pYC102.3 used, implying                           complementation experiments. COG009 Arg52 Lys56 essential YrdCEc function.                    split sub-families results pre- receiver strains tested sensitivity P1.              sented suggest distinct functions YciO YrdC.
results suggest nucleotide binding essential                  Like m1G37 	55, t6A37 tRNA
function proteins consistent                     modiï¬?cations present organisms known ATP requirement t6A biosynthesis (22).                           set tRNA sequences available (38,42).                                                                            universal modiï¬?cations believed                                                                            present common ancestor (43,44) DISCUSSION                                                                 sequenced genome (>600 date) YrdC results indicate universally conserved YrdC/                  ortholog.
Sua5 family involved biosynthesis N6-threonyl-                   study essentiality gene family carbamoyl adenosine. Deletion SUA5 led loss                   resolved. E. coli, yrdC appears essential, t6A independent yeast backgrounds. E. coli YrdC                     observed lack viability absence
preferentially bound tRNAThr containing modiï¬?ca-                       t6A modiï¬?cation remains established. tions t6A compared vitro (unmodiï¬?ed) tran-                    apparent contradiction results, insertion scribed tRNA. invariant residues involved                           PBAD promoter ï¬?rst 15 nucleotides yrdC
nucleotide binding characterized, strongly indicating                 reported lethal repressing conditions, role YrdC/Sua5 t6A biosynthesis mediated                 minimal rich medium (10). pheno- ATP binding hydrolyzing functions,                        type minimal medium attributed polar repres- suggesting direct role protein                   sion downstream aroE gene (aromatic amino-acid
biosynthetic pathway, ATP required t6A                        biosynthetic gene), essential growth mini-
formation (22).                                                            mal medium, LB aroE yrdC    YrdC/Sua5 proteins assigned                            considered essential.  expression COG009 organisms member                          pBAD promoter completely repressed glucose family. Exceptions include plants bacteria                (27,45), expression pBAD repression yield suf- homologs. Expression second                           ï¬?cient YrdC protein fulï¬?ll essential function(s) COG009 encoding gene E. coli, yciO, failed comple-                   cell.
ment t6A minus phenotype yeast strains lacking                       yeast, gene modiï¬?cation essen-
functional SUA5 gene. subfamilies                      tial, SUA5 deletion strains lacking t6A distinguished sequence analysis residues K50                     constructed  study (4)].  t6AÂ— strains
R52 positively charged                        display marked slow growth phenotype  study                                                                          Nucleic Acids Research, 2009, Vol. 37,  9 2907


(4)] possess defective mitochondria (4). mito-        recognition AUG  prokaryotic counter-
chondria considered prokaryotic origin, result      modiï¬?ed restricted recognizing
provides additional evidence modiï¬?cation plays        AUG, suggesting modiï¬?cation play essential role prokaryotic translation.                   important role selecting appropriate translational
   t6A modiï¬?cation shown determi-          start site. absence t6A, scanning ribosome
nant eï¬ƒcient aminoacylation bacterial Isoleucyl-         initiate natural ATG start codon, tRNA synthetase (IleRS), yeast            promiscuously ATG non-ATG codons, cytoplasmic IleRS (46,47) molecular       interactions initiator tRNAs codons
basis requirement YrdC Sua5 bacteria          stringent. account situa- yeast mitochondria, respectively.                       tion prokaryotes, initiator tRNA mod-
   mitochondrial tRNAs contain t6A (Lys, Ile, Arg2         iï¬?ed position 37 ribosome initiate Met) yrdC/SUA5 homolog                 ATG, GTG TTG (56). yeast, lack stringent identiï¬?ed yeast, protein predicted       translational start site selection lead cytoplasmic (48). absence mitochondrial          N-terminal variants, including active forms Cyc1
speciï¬?c homolog, Sua5 targeted mito-        protein account similar levels Cyc1
chondria, possibly alternative translational start site      activity seen sua5::LEU2 strain usage described proteins yeast          cyc1-1019 sua5-1 suppressor strain.
Trm5, HTS1, VAS1 Arabidopsis thaliana alanyl-,                 Finally, pleiotropic phenotypes linked threonyl- valyl-tRNA synthetases (49Â—52).                   absence YrdC/Sua5 members observed.    Strains lacking member YrdC/Sua5 family             E. coli, yrdC described possible ribosome
resulting defective pool tRNAs, instrumen-      maturation factor (RimN) needed correct processing
tal studying vivo role modiï¬?cation.           16S ribosomal RNA, maintenance normal
Accurate codonÂ—anticodon recognition critical insur-      amounts translating ribosomes (7,8). ribosome
ing accuracy translation t6A37 modiï¬?cation       maturation phenotype reï¬‚ect indirect consequence shown aï¬€ect process vitro, mainly        yrdC mutation tRNA defects loss preventing formation U33-A37 loop base        modiï¬?cations(s) cellular malfunctions pairing interaction, allowing cross-strand stacking      shown cause ribosome maturation defects (57).
A38 t6A37 ï¬?rst position codon (15,16,          conclusion, propose diverse phenotypes
18Â—20). t6A modiï¬?cation seven E. coli       YrdC/Sua5 mutant strains central 12 S. cerevisiae tRNAs, mitochondrial         primordial role t6A modiï¬?cation includes:
(38). eï¬€ects anticodon-surrounding modiï¬?ca-           insuring accurate decoding, maintaining reading
tions adjusting thermodynamic properties antic-       frame, selecting appropriate translation initiation
odon/codon interactions cognate cognate            codon (mainly Eukaryotes)  determining recogni-
recognition ribosome context dependent,        tion aminoacylation tRNAs prokaryotic expected absence t6A tRNAs aï¬€ect      mitochondrial IleRSs.
translation ways. reï¬‚ected pleio-        biochemical function YrdC/Sua5
tropic phenotypes strains lacking functional YrdC       proteins  e. catalytic activity) aside tRNA Sua5 (4Â—8). yeast, example, sua5-1 mutation      ATP binding  study) ATPase activity (41), isolated suppressor initiation defect aï¬€ecting   determined, appropriately modiï¬?ed tRNA sub-
CYC1 gene expression (4). CYC1 nuclear gene encod-         strates appear critical interacting proteins.
ing iso-1 form electron carrier protein cyto-        unable threonine binding YrdC,
chrome c localized mitochondria (53).           ATP binding conditions, incorporation cycl-1019 mutant expresses 2  normal                 threonine tRNAThr transcript presence iso-l-cytochrome c single base-pair          YrdC (data shown). experimentation using
substitution creates upstream ATG codon         apomodiï¬?ed tRNA substrate needed determine frame normal CYCl translational start.          role YrdC t6A biosynthesis. likely sua5-1 point mutation suppressed translational         protein partners interact YrdC especially defect, restoring Cyc1 levels 60  normal levels       biosynthesis t6A proposed require ATP-
(4). sua5 suppressor strain lacking t6A  study),   dependent steps (58).
Cyc1 protein expression possibly high levels frameshift errors translation initiated upstream frame ATG, restoring orig-
                                                                ACKNOWLEDGEMENTS
inal reading frame. absence modiï¬?cations position 37 Wyeosine m1G shown         authors like thank Michael Hampsey drastically increase frame-shifting yeast (54,55).        strains plasmids, Sophie Alvares LC/MS/MS  fact Cyc1 protein expressed       analysis, Iris Porat William Whitman M. maripa- nearly wild-type levels wild-type CYC1               ludis genomic DNA, Darrell Davies t6A standard,
sua5::LEU2 strain (4), e. absence aberrant      John Aris advice regarding yeast genetics, Henri
ATG cyc1-1019 allele, suggests         Grosjean Paul Agris insightful discussions hypothesis. Eukaryotes, cytoplasmic initiator            Nemat Keyhani critical reading editing tRNA contains t6A position 37, restricted        manuscript.
 2908 Nucleic Acids Research, 2009, Vol. 37,  9


FUNDING                                                                    16. Murphy,F.V., Ramakrishnan,V., Malkiewicz  Agris,P.F.
                                                                               (2004) role modiï¬?cations codon discrimination National Science Foundation (grant MCB-05169448);                           tRNALysUUU. Nat. Struct. Mol. Biol., 11, 1186Â—1191.
U.S. Department Energy (grant  FG02Â—                              17. Schweisguth,D.C. Moore,P.B. (1997) conformation 07ER64498)  V.D.C.]; National Institutes Health                          anticodon loops initiator elongator methionine tRNAs.
                                                                               J. Mol. Biol., 267, 505Â—519.
(GM-23562)  P.S.]. Funding open access charge:                      18. Stuart,J.W., Gdaniec , Guenther,R., Marszalek,M., Sochacka,E.,
U.S. Department Energy (grant  FG02Â—                                  Malkiewicz  Agris,P.F. (2000) Functional anticodon
07ER64498).                                                                    architecture human tRNALys3 includes disruption intraloop
                                                                               hydrogen bonding naturally occurring amino acid
Conï¬‚ict statement. declared.                                  modiï¬?cation, t6A. Biochemistry, 39, 13396Â—13404.
                                                                           19. Weissenbach,J. Grosjean,H. (1981) Eï¬€ect threonylcarbamoyl
                                                                               modiï¬?cation (t6A) yeast tRNA Arg III codon-anticodon                                                                                anticodon-anticodon interactions. thermodynamic kinetic
REFERENCES                                                                     evaluation. Eur. J. Biochem., 116, 207Â—213.
                                                                           20. Yarian,C., Marszalek,M., Sochacka,E., Malkiewicz ,
 1. Galperin,M.Y. Koonin,E.V. (2004) â€˜Conserved hypotheticalâ€™              Guenther,R., Miskiewicz  Agris,P.F. (2000) Modiï¬?ed
    proteins: prioritization targets experimental study. Nucleic        nucleoside dependent Watson-Crick wobble codon binding     Acids Res., 32, 5452Â—5463.                                                 tRNALysUUU species. Biochemistry, 39, 13390Â—13395.
 2. Teplova,M., Tereshko,V., Sanishvili,R., Joachimiak ,                 21. Yarian,C., Townsend,H., Czestkowski,W., Sochacka,E.,
    Bushueva,T., Anderson,W.F. Egli,M. (2000) structure                Malkiewicz J., Guenther,R., Miskiewicz  Agris,P.F. (2002)
    yrdC gene product Escherichia coli reveals new               Accurate translation genetic code depends tRNA modiï¬?ed
    fold suggests role RNA binding. Protein Sci., 9,                  nucleosides. J. Biol. Chem., 277, 16391Â—16395.
    2557Â—2566.                                                             22. Elkins,B.N. Keller,E.B. (1974) enzymatic synthesis  3. Jia,J., Lunin,V.V., Sauve,V., Huang,L.W., Matte  Cygler,M.           N-(purin-6-ylcarbamoyl)threonine, anticodon-adjacent base     (2002) Crystal structure YciO protein Escherichia coli.        transfer ribonucleic acid. Biochemistry, 13, 4622Â—4628.
    Proteins, 49, 139Â—141.                                                 23. Overbeek,R., Begley,T., Butler,R.M., Choudhuri,J.V.,
 4. Na,J.G., Pinto  Hampsey,M. (1992) Isolation                      Chuang,H.Y., Cohoon,M., CreÂ´cy-Lagard,V., Diaz,N., Disz,T.,
    characterization SUA5, novel gene required normal growth          Edwards,R. et al. (2005) subsystems approach genome
    Saccharomyces cerevisiae. Genetics, 131, 791Â—801.                       annotation use project annotate 1000 genomes.
 5. Chen,J., Ji,C., Gu,S., Zhao,E., Dai,J., Huang,L., Qian,J., Ying,K.,        Nucleic Acids Res., 33, 5691Â—5702.
    Xie,Y. Mao,Y. (2003) Isolation identiï¬?cation novel        24. Altschul,S.F., Madden,T.L., Schaï¬€er , Zhang,J., Zhang ,
    cDNA encodes human YrdC protein. J. Hum. Genet., 48,                  Miller,W. Lipman,D.J. (1997) Gapped BLAST PSI-
    164Â—169.                                                                   BLAST: new generation protein database search programs.
 6. Jiang,W., Prokopenko,O., Wong,L., Inouye,M.                            Nucleic Acids Res., 25, 3389Â—3402.
    Mirochnitchenko,O. (2005) IRIP, new ischemia/reperfusion-            25. Chenna,R., Sugawara,H., Koike,T., Lopez,R., Gibson,T.J.,
    inducible protein participates regulation transporter       Higgins,D.G. Thompson,J.D. (2003) Multiple sequence
    activity. Mol. Cell Biol., 25, 6496Â—6508.                                  alignment Clustal series programs. Nucleic Acids Res.,
 7. Kaczanowska,M. Ryden-Aulin,M. (2005) YrdC protein Â—                31, 3497Â—3500.
    putative ribosome maturation factor. Biochim. Biophys. Acta,         26. Miller,J.H. (1972) Experiments Molecular Genetics. Cold Spring
    1727, 87Â—96.                                                               Harbor Laboratory Press, Cold Spring Harbor, NY.
 8. Kaczanowska,M. Ryden-Aulin,M. (2004) Temperature                   27. Guzman,L.M., Belin,D., Carson,M.J. Beckwith,J. (1995) Tight
    sensitivity caused mutant release factor 1 suppressed             regulation, modulation, high-level expression vectors
    mutations aï¬€ect 16S rRNA maturation. J. Bacteriol., 186,              containing arabinose PBAD promoter. J. Bacteriol., 177,
    3046Â—3055.                                                                 4121Â—4130.
 9. Baba,T., Ara,T., Hasegawa,M., Takai,Y., Okumura,Y., Baba,M.,           28. Sikorski,R.S. Hieter,P. (1989) shuttle vectors     Datsenko,K , Tomita,M., Wanner,B.L. Mori,H. (2006)                   yeast host strains designed eï¬ƒcient manipulation DNA     Construction Escherichia coli K-12 frame, single-gene                Saccharomyces cerevisiae. Genetics, 122, 19Â—27.
    knockout mutants: Keio collection. Mol. Syst. Biol., 2,            29. Datsenko,K  Wanner,B.L. (2000) step inactivation     2006.0008.                                                                 chromosomal genes Escherichia coli K-12 using PCR products.
10. Serina,S., Nozza,F., Nicastro,G., Faggioni,F., Mottl,H., Deho,G.           Proc. Natl Acad. Sci. USA, 97, 6640Â—6645.
    Polissi  (2004) Scanning Escherichia coli chromosome      30. Yu,D., Ellis,H.M., Lee,E.C., Jenkins,N , Copeland,N.G.     random transposon mutagenesis multiple phenotypic screening.           Court,D.L. (2000) eï¬ƒcient recombination     Res. Microbiol., 155, 692.                                                 chromosome engineering Escherichia coli. Proc. Natl Acad. Sci.
11. Giaever,G., Chu M., Ni,L., Connelly,C., Riles,L., Veronneau,S.,          USA, 97, 5978Â—5983.
    Dow,S., Lucau-Danila , Anderson,K., Andre,B. et al. (2002)           31. Boeke,J.D., LaCroute,F. Fink,G.R. (1984) positive selection
    Functional proï¬?ling Saccharomyces cerevisiae genome.                mutants lacking orotidine-50 -phosphate decarboxylase activity     Nature, 418, 387Â—391.                                                      yeast: 5-ï¬‚uoro-orotic acid resistance. Mol. Gen. Genet., 197,
12. Ashraf,S.S., Guenther,R., Ye,W., Lee,Y., Malkiewicz                  345Â—346.
    Agris,P.F. (1997) Ribosomal binding modiï¬?ed tRNA anticodons         32. Pomerantz,S.C. McCloskey,J  (1990) Analysis RNA
    related thermal stability. Nucleic Acids Symp. Ser., 36, 58Â—60.         hydrolyzates liquid chromatography-mass spectrometry.
13. Basavappa,R. Sigler,P.B. (1991) 3  crystal structure          Methods Enzymol., 193, 796Â—824.
    yeast initiator tRNA: functional implications initiator/elongator   33. Waas,W.F. Schimmel,P. (2007) Evidence tRNA
    discrimination. EMBO J., 10, 3105Â—3111.                                    synthetase-directed proton transfer stops mistranslation.
14. Durant,P.C., Bajji C., Sundaram,M., Kumar,R.K.                       Biochemistry, 46, 12062Â—12070.
    Davis,D.R. (2005) Structural eï¬€ects hypermodiï¬?ed nucleosides     34. Shields,T.P., Mollova,E., Ste Marie,L., Hansen,M.R. Pardi 
    Escherichia coli human tRNALys anticodon loop: eï¬€ect           (1999) High-performance liquid chromatography puriï¬?cation     nucleosides s2U, mcm5U, mcm5s2U, mnm5s2U, t6A, ms2t6A.              homogenous-length RNA produced trans cleavage     Biochemistry, 44, 8078Â—8089.                                               hammerhead ribozyme. RNA, 5, 1259Â—1267.
15. Lescrinier,E., Nauwelaerts,K., Zanier,K., Poesen,K., Sattler,M.    35. Vieira,J. Messing,J. (1982) pUC plasmids,     Herdewijn,P. (2006) naturally occurring N6-threonyl adenine         M13mp7-derived insertion mutagenesis sequencing
    anticodon loop Schizosaccharomyces pombe tRNAi causes                   synthetic universal primers. Gene, 19, 259Â—268.
    formation unique U-turn motif. Nucleic Acids Res., 34,            36. Kurganov,B , Sugrobova,N.P. Yakovlev,V  (1972)
    2878Â—2886.                                                                 Estimation dissociation constant enzyme-ligand complex
                                                                                      Nucleic Acids Research, 2009, Vol. 37,  9 2909


    ï¬‚uorometric data â€˜â€˜diï¬€erenceâ€™â€™ method. FEBS Lett., 19,         49. Chatton,B., Walter,P., Ebel,J.P., Lacroute,F. Fasiolo,F. (1988)
    308Â—310.                                                                   yeast VAS1 gene encodes mitochondrial cytoplasmic
37. Mayer,M. Bernd,M. (1999) Characterization ligand binding            valyl-tRNA synthetases. J. Biol. Chem., 263, 52Â—57.
    saturation transfer diï¬€erence NMR spectroscopy. Angew. Chem.,       50. Lee,C., Kramer,G., Graham,D.E. Appling,D.R. (2007) Yeast
    Int. Ed., 38, 1784Â—1788.                                                   mitochondrial initiator tRNA methylated guanosine 37 38. Sprinzl,M. Vassilenko,K.S. (2005) Compilation tRNA                  Trm5-encoded tRNA (Guanine-N1-)-methyltransferase. J. Biol.